Showing results (931-940 of 981) with videos related to
Sort By:
Pageof 99
Blood|January 22, 2011
Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phaseQian Jiang, Lan-Ping Xu, Dai-Hong Liu, et al.Frontiers in Oncology|March 4, 2021
Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort StudyYuan Wang, Lan-Lan Feng, Pei-Gang Ji, et al.Frontiers in Oncology|June 6, 2022
Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent ChemoradiotherapyDa-Wei Zhao, Xue-Mei Fang, Shu-Han Zhou, et al.Molecular Cancer|February 7, 2014
The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myelomaYao Zhang, Li Bao, Jin Lu, et al.European Journal of Haematology|April 14, 2020
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myelomaZi-Long Wang, Yang Liu, Ya-Lan Zhou, et al.Genome Biology|February 28, 2025
Admixture as a source for HLA variation in Neolithic European farming communitiesNicolas Antonio da Silva, Onur Özer, Magdalena Haller-Caskie, et al.Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.Journal of Hematology & Oncology|April 2, 2020
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized studyYing-Jun Chang, Yu Wang, Lan-Ping Xu, et al.Nature Communications|February 16, 2026
GCN5 drives MASLD progression through LXRα/SREBP1c signaling pathway-mediated de novo lipogenesisHai-Tao Xiao, Peng Song, Jing Jin, et al.British Journal of Haematology|March 28, 2019
S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemiaJing Zhang, Wen-Yi Lu, Jia-Min Zhang, et al.Pageof 99